EUVIMEDEUVIMED entdecken
Crossref

Differential burden of five major mental disorders in the United States across the COVID-19 pandemic

Ze Jin

European Archives of Psychiatry and Clinical Neuroscience · 2026

DOI: 10.1007/s00406-026-02308-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Psychiatry and Clinical Neuroscience, 2026. Verfasst von Ze Jin. Beteiligte Einrichtung: Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY, 10029, USA. ze.jin@icahn.mssm.edu. Hauptthemen laut MEDLINE: COVID-19, Anxiety Disorders, Major Depressive Disorder, Bipolar Disorder. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to simultaneously characterize the long-term burden trajectories of five major mental disorders across all US states from 1990 to 2023, including their responses to the COVID-19 pandemic. METHODS: Age-standardized prevalence and years lived with disability rates for five mental disorders [anxiety disorders, major depressive disorder (MDD), dysthymia, bipolar disorder, and schizophrenia] were analyzed across US states from 1990 to 2023 using Global Burden of Disease Study data, stratified by sex and age, examining temporal trends, pandemic-period changes, geographic distributions, Socio-demographic Index (SDI) correlations, and cross-disorder associations. RESULTS: From 1990 to 2023, anxiety disorders and MDD prevalence increased by 25.4% and 55.2%, while dysthymia (-6.7%), bipolar disorder (-1.0%), and schizophrenia (-5.3%) declined modestly; in 2023, female prevalence of anxiety disorders and MDD exceeded male rates by 77.1% and 79.3%. During 2019-2023, anxiety disorders and MDD prevalence surged by 47.9% and 23.7%, reversing pre-pandemic declining trends of -1.2% and -1.8%, yielding between-period differences of +49.2 and +25.6 percentage points, universally across all 51 states. MDD exhibited the widest disparity, ranging from 2291 per 100,000 in North Dakota to 4803 per 100,000 in West Virginia. SDI was inversely associated with anxiety disorders (ρ = -0.335) and MDD (ρ = -0.355), but positively associated with schizophrenia (ρ = 0.689; all P < 0.05). State-level schizophrenia prevalence was negatively associated with MDD (β = -57.252, P = 0.007) and anxiety disorders (β = -19.597, P = 0.006). CONCLUSION: The COVID-19 pandemic selectively accelerated anxiety and depressive disorder burden across all US states. Substantial geographic disparities, disorder-specific sociodemographic gradients, and cross-disorder ecological patterns were identified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Anxiety DisordersMajor Depressive DisorderBipolar DisorderSchizophreniaDysthymic DisorderCost of IllnessHumansUnited StatesFemaleMalePrevalenceAdultMiddle AgedAged

Stichwörter der Autor:innen

COVID-19 pandemicMental disordersState-levelUnited States

Autor:innen und Institutionen

  • Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY, 10029, USA. ze.jin@icahn.mssm.edu.

Zitieren

APA

Jin, Z. (2026). Differential burden of five major mental disorders in the United States across the COVID-19 pandemic. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-026-02308-9

Vancouver

Jin Z. Differential burden of five major mental disorders in the United States across the COVID-19 pandemic. European Archives of Psychiatry and Clinical Neuroscience. 2026. doi:10.1007/s00406-026-02308-9

BibTeX
@article{Jin2026,
  author = {Jin, Ze},
  title = {Differential burden of five major mental disorders in the United States across the COVID-19 pandemic},
  journal = {European Archives of Psychiatry and Clinical Neuroscience},
  year = {2026},
  doi = {10.1007/s00406-026-02308-9}
}
Kostenlos starten →